Examining the Tumor Microenvironment with Patient-Derived Xenografts (PDX)
Examining the tumor microenvironment with patient-derived xenografts (PDX)
Advancing therapeutic research for long COVID with an enhanced hACE2 mouse model
Envigo, an Inotiv company, is leading the charge to advance therapeutic research for long COVID with an enhanced hACE2 mouse model.
Supporting research with standard and transgenic rodent models: A historical overview
Since the first published article mentioning the use of a rat as a small laboratory model in 1856, rodent models have helped advance critical biomedical research and enhanced drug discovery...
Inbred and outbred rodent strains: What you need to know for your research
The genetic diversity of rodents used in drug development studies plays a role in both replicating research and understanding the differences in a treatment due to heterogeneity of a model. To help...
Advancing cancer immunotherapy research with rodent models
Immunotherapies have offered new hope to patients that haven’t responded to traditional cancer treatments. While many of these breakthroughs have improved survival rates and patient outcomes, ongoing...
Going beyond the guidelines: How Inotiv invests in animal welfare
As research has evolved, so have best practices for promoting animal health and welfare. Inotiv's Director of Veterinary Sciences EMEA (DVS), shares how they've seen animal welfare shift over the...
Enabling toxicology and carcinogenicity testing with the Wistar Han rat
The Wistar Hannover rat, also known as RccHan®:WIST and HsdHan®:WIST, is considered a strain of choice for toxicology and carcinogenicity studies, helping advance research for many multinational...
